secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kezar Life Sciences, Inc. (KZR)
CIK:        0001645666
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0001645666-25-000001
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Kezar Life Sciences reports preliminary cash of $132.2M as of Dec 31, 2024
--------------------------------------------------------------------------

- Preliminary cash, equivalents, and marketable securities at $132.2M as of December 31, 2024.
- Shares outstanding of 7.3 million as of December 31, 2024.
- Estimates are unaudited, subject to year-end closing adjustments; not a comprehensive financial statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645666/000164566625000001/0001645666-25-000001-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645666/000164566625000001/kzr-20250110.htm
  HTML page:      https://secwatch.observer/filing/0001645666-25-000001

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer